Company / Tangible Book Value per Share
MADRIGAL PHARMACEUTICALS, INC. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$27.39
FY2025
5-year range
$11.52 / $37.96
FY2021-FY2025
Trend
-27.8%
vs FY2024
Sector context
#15 of 209
Health Care
What the data says
Among 209 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the top 7% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $7.00 in FY2016 to $37.96 in FY2024.
Based on SEC 10-K filings.
27.39 in FY2025 with a 5-year CAGR of +12.0%. Top quartile in the Health Care sector.
Improved from $22.39 to $27.39 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +33.5%
- 5-Year CAGR
- +12.0%
- 10-Year CAGR
- -
Sector benchmark
-70.7% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 27.8% year-over-year.
- Ranks #15 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.39 | -27.8% |
| FY2024 | $37.96 | +69.5% |
| FY2023 | $22.39 | +94.4% |
| FY2022 | $11.52 | -8.9% |
| FY2021 | $12.65 | -18.7% |
| FY2020 | $15.55 | -42.5% |
| FY2019 | $27.06 | -16.1% |
| FY2018 | $32.24 | +116.6% |
| FY2017 | $14.88 | +112.8% |
| FY2016 | $7.00 | +1517.4% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026